Cognitive
Cyclic Glycine-Proline
Longevity
0
Amino acids
Molecular weight
Peptide
Type
Endogenous cyclic dipeptide found in plasma, breast milk, and cerebrospinal fluid. Functions as metabolite of IGF-1, regulating its bioavailability through competitive binding to IGFBP-3. Demonstrates neuroprotective, cognitive-enhancing, and cardioprotective properties supported by clinical trials.
Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors. Increases BDNF levels via Akt/MDM2-p53 pathway activation.
Room temperature in sealed container, protected from moisture and light
Once daily, preferably in the morning
20-100 μg daily (or 300mg blackcurrant extract 2x daily)
4-12 weeks
No visual available
Due to this peptide having no amino acids, there is no molecular chain to display.
Neuroprotection and cognitive enhancement
IGF-1 optimization
Cardiovascular support
Metabolic health improvement
Blood-brain barrier penetration
Convenient oral administration
This peptide is still gaining traction in the community.
IGF-1 Bioavailability Regulator & Neuroprotective Peptide
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Cyclic Glycine-Proline.
Preferred route with excellent bioavailability and blood-brain barrier crossing.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| General cognitive support | 20 | 1 week range | Oral capsule |
| Neuroprotection/anti-aging | 40 | 1 week range | Oral capsule |
| Metabolic/cardiovascular support | 40 | 1 week range | Oral capsule |
| Via blackcurrant extract | 300 | 2 week range | Oral capsule |
The Cyclic Glycine-Proline Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Cyclic Glycine-Proline
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Cyclic Glycine-Proline vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Cyclic Glycine-Proline interactions with other common peptides and substances.
Healing
bpc
Longevity
COMPATIBLE
Different pathways; BPC-157 promotes tissue repair, cGP modulates IGF-1
Cognitive
sel
Longevity
COMPATIBLE
Complementary cognitive effects; Selank addresses anxiety, cGP optimizes IGF-1
Cognitive
sema
Longevity
COMPATIBLE
Both offer neuroprotection and nootropic effects through distinct pathways
Consult healthcare provider if taking IGF-1 or growth hormone medications
Limited long-term human data available
Not studied in pregnancy
Allergic reactions (rash, difficulty breathing, swelling)
Unexpected blood glucose changes
Unusual fatigue or weakness
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Cyclic Glycine-Proline is a moderate research compound
Cyclic Glycine-Proline
Cyclic Glycine-Proline is a moderate research compound
IGF-1 Homeostasis Regulation Study
cGP regulates IGF-1 bioavailability through IGFBP-3 competitive binding
n.d.
Alzheimer's Mouse Model Study
Significantly improved spatial memory; reduced hippocampal plaques 42.3→14.5 per mm²
n.d.
Parkinson's Disease Clinical Study
Blackcurrant supplementation increased CSF cGP 74%; reduced anxiety/depression
n.d.
Stroke Recovery & Cognitive Function Review
Higher cGP/IGF-1 ratios associated with favorable stroke outcomes
n.d.